Healthcare provider profile · identity verified

Melissa Schiffman, MD

Internal Medicine · WYNCOTE, PA · NPI 1639148091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	735	211
Amlodipine Besylate	Amlodipine Besylate	574	163
Rosuvastatin Calcium	Rosuvastatin Calcium	395	111
Losartan Potassium	Losartan Potassium	267	78
Gabapentin	Gabapentin	228	56
Pantoprazole Sodium	Pantoprazole Sodium	214	53
Metoprolol Succinate	Metoprolol Succinate	205	59
Levothyroxine Sodium	Levothyroxine Sodium	204	50
Albuterol Sulfate Hfa	Albuterol Sulfate	202	57
Ozempic	Semaglutide	200	34
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	196	52
Metformin Hcl Er	Metformin Hcl	195	50
Furosemide	Furosemide	192	67
Carvedilol	Carvedilol	173	49
Valsartan	Valsartan	173	58
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	170	53
Jardiance	Empagliflozin	168	36
Duloxetine Hcl	Duloxetine Hcl	157	48
Hydrochlorothiazide	Hydrochlorothiazide	153	46
Omeprazole	Omeprazole	138	39
Clopidogrel	Clopidogrel Bisulfate	134	30
Lisinopril	Lisinopril	120	38
Diclofenac Sodium	Diclofenac Sodium	119	35
Nifedipine Er	Nifedipine	119	39
Famotidine	Famotidine	116	30
Trulicity	Dulaglutide	110	20
Trazodone Hcl	Trazodone Hcl	108	35
Fluticasone Propionate	Fluticasone Propionate	101	45
Celecoxib	Celecoxib	94	30
Allopurinol	Allopurinol	79	17
Eliquis	Apixaban	78	21
Montelukast Sodium	Montelukast Sodium	76	22
Metformin Hcl	Metformin Hcl	75	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	16
Lidocaine	Lidocaine	73	20
Mirtazapine	Mirtazapine	66	21
Glipizide Er	Glipizide	65	15
Spironolactone	Spironolactone	63	22
Pravastatin Sodium	Pravastatin Sodium	61	15
Farxiga	Dapagliflozin Propanediol	59	suppressed
Donepezil Hcl	Donepezil Hcl	57	15
Clonidine Hcl	Clonidine Hcl	56	suppressed
Mounjaro	Tirzepatide	56	13
Tamsulosin Hcl	Tamsulosin Hcl	56	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	16
Prednisone	Prednisone	53	38
Simvastatin	Simvastatin	52	17
Ezetimibe	Ezetimibe	51	19
Tizanidine Hcl	Tizanidine Hcl	51	12
Escitalopram Oxalate	Escitalopram Oxalate	50	14
Chlorthalidone	Chlorthalidone	48	13
Potassium Chloride	Potassium Chloride	47	16
Triamcinolone Acetonide	Triamcinolone Acetonide	44	22
Azelastine Hcl	Azelastine Hcl	41	17
Olmesartan Medoxomil	Olmesartan Medoxomil	40	14
Lorazepam	Lorazepam	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Alprazolam	Alprazolam	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	33	suppressed
Pregabalin	Pregabalin	33	12
Valacyclovir	Valacyclovir Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Atenolol	Atenolol	31	suppressed
Colchicine	Colchicine	31	suppressed
Epinephrine	Epinephrine	30	suppressed
Repaglinide	Repaglinide	30	suppressed
Glipizide	Glipizide	29	11
Novolog Flexpen	Insulin Aspart	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	suppressed
Sertraline Hcl	Sertraline Hcl	28	14
Bumetanide	Bumetanide	27	suppressed
Xarelto	Rivaroxaban	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	16
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Buspirone Hcl	Buspirone Hcl	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Azithromycin	Azithromycin	20	18
Mometasone Furoate	Mometasone Furoate	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Estradiol	Estradiol	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Lactulose	Lactulose	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	11
Ammonium Lactate	Ammonium Lactate	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Baclofen	Baclofen	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Clonidine	Clonidine	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Synthroid	Levothyroxine Sodium	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Invokana	Canagliflozin	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Diazepam	Diazepam	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error